Since mammalian HSF1 has been shown to support progression of highly malignant cancers (Dai et al. 2007; Mendillo et al. 2012), it is crucial to develop strategies that can selectively modulate the activity of this transcription factor to promote longevity in animals without producing undesired outcomes. Here, HSF1 is linked to cancer.